Sustained phosphorylation of Bid is a marker for resistance to fas-induced apoptosis during chronic liver diseases

Gastroenterology

Volumn 130, Issue 1, 2006, Pages 104-119

  Vogel, Arndt ^a,b   Aslan, Joseph E ^a   Willenbring, Holger ^a   Klein, Christian ^b   Finegold, Milton ^c   Mount, Howard ^d   Thomas, Gary ^a   Grompe, Markus ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BAG 1 PROTEIN; BIM PROTEIN; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; FAS ANTIBODY; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; MONOCLONAL ANTIBODY; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; PROTEIN BID; PROTEIN FAS RECEPTOR; PROTEIN MCL 1; RECEPTOR; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; CELL DEATH; CHOLESTASIS; CHRONIC DISEASE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME ACTIVATION; LIVER CELL; LIVER MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRESS;

EID: 30044442328     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.10.012     Document Type: Article

References (67)

1. P.R. Galle, P.H. Krammer CD95-induced apoptosis in human liver disease Semin Liver Dis 18 1998 141 151
2. A. Vogel, I.E. van Den Berg, M. Al-Dhalimy, J. Groopman, C.N. Ou, O. Ryabinina, M.S. Iordanov, M. Finegold, M. Grompe Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death Hepatology 39 2004 433 443
3. J. Findor, X.S. He, J. Sord, R. Terg, M.E. Gershwin Primary biliary cirrhosis and hepatocellular carcinoma Autoimmun Rev 1 2002 220 225
4. L. Caballeria, A. Pares, A. Castells, A. Gines, C. Bru, J. Rodes Hepatocellular carcinoma in primary biliary cirrhosis similar incidence to that in hepatitis C virus-related cirrhosis Am J Gastroenterol 96 2001 1160 1163
5. E.B. Keeffe, C.W. Pinson, J. Ragsdale, J. Zonana Hepatocellular carcinoma in arteriohepatic dysplasia Am J Gastroenterol 88 1993 1446 1449
6. G.J. Gores Cholangiocarcinoma current concepts and insights Hepatology 37 2003 961 969
7. H. Higuchi, H. Miyoshi, S.F. Bronk, H. Zhang, N. Dean, G.J. Gores Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury J Pharmacol Exp Ther 299 2001 866 873
8. B. Yerushalmi, R. Dahl, M.W. Devereaux, E. Gumpricht, R.J. Sokol Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition Hepatology 33 2001 616 626
9. M.H. Schoemaker, W.M. Gommans, L.C. de la Rosa, M. Homan, P. Klok, C. Trautwein, H. van Goor, K. Poelstra, H.J. Haisma, P.L. Jansen, H. Moshage Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation J Hepatol 39 2003 153 161
10. P. Fickert, M. Trauner, A. Fuchsbichler, G. Zollner, M. Wagner, H.U. Marschall, K. Zatloukal, H. Denk Oncosis represents the main type of cell death in mouse models of cholestasis J Hepatol 42 2005 378 385
11. J.S. Gujral, J. Liu, A. Farhood, H. Jaeschke Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation Hepatology 40 2004 998 1007
12. M. Grompe, M. Al-Dhalimy, M. Finegold, C.N. Ou, T. Burlingame, N.G. Kennaway, P. Soriano Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice Genes Dev 7 1993 2298 2307
13. W.A. Faubion, M.E. Guicciardi, H. Miyoshi, S.F. Bronk, P.J. Roberts, P.A. Svingen, S.H. Kaufmann, G.J. Gores Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas J Clin Invest 103 1999 137 145
14. S.T. Eichhorst, A. Kruger, S. Muerkoster, S.C. Fas, A. Golks, U. Gruetzner, L. Schubert, C. Opelz, M. Bilzer, A.L. Gerbes, P.H. Krammer Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice Nat Med 10 2004 602 609
15. X. Ge, Y.M. Fu, Y.Q. Li, G.G. Meadows Activation of caspases and cleavage of Bid are required for tyrosine and phenylalanine deficiency-induced apoptosis of human A375 melanoma cells Arch Biochem Biophys 403 2002 50 58
16. M.A. Bird, D. Black, P.A. Lange, C.M. Samson, M. Hayden, K.E. Behrns NFkappaB inhibition decreases hepatocyte proliferation but does not alter apoptosis in obstructive jaundice J Surg Res 114 2003 110 117
17. E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, Y. Ben-Neriah NF-kappaB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466
18. F. Kuhnel, L. Zender, Y. Paul, M.K. Tietze, C. Trautwein, M. Manns, S. Kubicka NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis J Biol Chem 275 2000 6421 6427
19. M.B. Arvelo, J.T. Cooper, C. Longo, S. Daniel, S.T. Grey, J. Mahiou, E. Czismadia, G. Abu-Jawdeh, C. Ferran A20 protects mice from D-galactosamine/ lipopolysaccharide acute toxic lethal hepatitis Hepatology 35 2002 535 543
20. E. Hatano, B.L. Bennett, A.M. Manning, T. Qian, J.J. Lemasters, D.A. Brenner NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis Gastroenterology 120 2001 1251 1262
21. L.G. Cavin, M. Venkatraman, V.M. Factor, S. Kaur, I. Schroeder, F. Mercurio, A.A. Beg, S.S. Thorgeirsson, M. Arsura Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis Cancer Res 64 2004 7030 7038
22. L. Zender, S. Hutker, B. Mundt, M. Waltemathe, C. Klein, C. Trautwein, N.P. Malek, M.P. Manns, F. Kuhnel, S. Kubicka NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis Hepatology 41 2005 280 288
23. S. Camandola, R.G. Cutler, D.S. Gary, O. Milhavet, M.P. Mattson Suppression of calcium release from inositol 1,4,5-trisphosphate-sensitive stores mediates the anti-apoptotic function of nuclear factor-{kappa}B J Biol Chem 280 2005 22287 22296
24. M. Nagaki, T. Naiki, D.A. Brenner, Y. Osawa, M. Imose, H. Hayashi, Y. Banno, S. Nakashima, H. Moriwaki Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis role of nuclear factor-kappaB Hepatology 32 2000 1272 1279
25. R.A. DeAngelis, K. Kovalovich, D.E. Cressman, R. Taub Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice Hepatology 33 2001 915 924
26. S. Finotto, J. Siebler, M. Hausding, M. Schipp, S. Wirtz, S. Klein, M. Protschka, A. Doganci, H.A. Lehr, C. Trautwein, R. Khosravi-Far, D. Strand, A. Lohse, P.R. Galle, M. Blessing, M.F. Neurath Severe hepatic injury in interleukin 18 (IL-18) transgenic mice a key role for IL-18 in regulating hepatocyte apoptosis in vivo Gut 53 2004 392 400
27. D.J. Van Antwerp, S.J. Martin, T. Kafri, D.R. Green, I.M. Verma Suppression of TNF-alpha-induced apoptosis by NF-kappaB Science 274 1996 787 789
28. R.M. Siegel, J.K. Frederiksen, D.A. Zacharias, F.K. Chan, M. Johnson, D. Lynch, R.Y. Tsien, M.J. Lenardo Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations Science 288 2000 2354 2357
29. K.M. Boatright, M. Renatus, F.L. Scott, S. Sperandio, H. Shin, I.M. Pedersen, J.E. Ricci, W.A. Edris, D.P. Sutherlin, D.R. Green, G.S. Salvesen A unified model for apical caspase activation Mol Cell 11 2003 529 541
30. G.S. Salvesen, V.M. Dixit Caspase activation the induced-proximity model Proc Natl Acad Sci USA 96 1999 10964 10967
31. C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li, K.J. Tomaselli, K.M. Debatin, P.H. Krammer, M.E. Peter Two CD95 (APO-1/Fas) signaling pathways EMBO J 17 1998 1675 1687
32. H. Li, H. Zhu, C.J. Xu, J. Yuan Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 94 1998 491 501
33. X. Luo, I. Budihardjo, H. Zou, C. Slaughter, X. Wang Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 94 1998 481 490
34. A.B. Werner, E. de Vries, S.W. Tait, I. Bontjer, J. Borst Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit in collaboration with pro-apoptotic Bak or Bax J Biol Chem 277 2002 22781 22788
35. S. Desagher, A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, S. Lauper, K. Maundrell, B. Antonsson, J.C. Martinou Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis J Cell Biol 144 1999 891 901
36. R. Eskes, S. Desagher, B. Antonsson, J.C. Martinou Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane Mol Cell Biol 20 2000 929 935
37. M.C. Wei, T. Lindsten, V.K. Mootha, S. Weiler, A. Gross, M. Ashiya, C.B. Thompson, S.J. Korsmeyer tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c Genes Dev 14 2000 2060 2071
38. S. Shimizu, M. Narita, Y. Tsujimoto Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC Nature 399 1999 483 487
39. D. Acehan, X. Jiang, D.G. Morgan, J.E. Heuser, X. Wang, C.W. Akey Three-dimensional structure of the apoptosome implications for assembly, procaspase-9 binding, and activation Mol Cell 9 2002 423 432
40. A. Krueger, I. Schmitz, S. Baumann, P.H. Krammer, S. Kirchhoff Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex J Biol Chem 276 2001 20633 20640
41. X. Wang The expanding role of mitochondria in apoptosis Genes Dev 15 2001 2922 2933
42. S. Cory, D.C. Huang, J.M. Adams The Bcl-2 family roles in cell survival and oncogenesis Oncogene 22 2003 8590 8607
43. A. Gross, J.M. McDonnell, S.J. Korsmeyer BCL-2 family members and the mitochondria in apoptosis Genes Dev 13 1999 1899 1911
44. Y.T. Hsu, K.G. Wolter, R.J. Youle Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis Proc Natl Acad Sci U S A 94 1997 3668 3672
45. M.C. Wei, W.X. Zong, E.H. Cheng, T. Lindsten, V. Panoutsakopoulou, A.J. Ross, K.A. Roth, G.R. MacGregor, C.B. Thompson, S.J. Korsmeyer Proapoptotic BAX and BAK a requisite gateway to mitochondrial dysfunction and death Science 292 2001 727 730
46. M. Degli Esposti, G. Ferry, P. Masdehors, J.A. Boutin, J.A. Hickman, C. Dive Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3 J Biol Chem 278 2003 15749 15757
47. S. Desagher, A. Osen-Sand, S. Montessuit, E. Magnenat, F. Vilbois, A. Hochmann, L. Journot, B. Antonsson, J.C. Martinou Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8 Mol Cell 8 2001 601 611
48. U. Knippschild, D.M. Milne, L.E. Campbell, A.J. DeMaggio, E. Christenson, M.F. Hoekstra, D.W. Meek p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs Oncogene 15 1997 1727 1736
49. K. Sakaguchi, S. Saito, Y. Higashimoto, S. Roy, C.W. Anderson, E. Appella Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding J Biol Chem 275 2000 9278 9283
50. N.C. Ha, T. Tonozuka, J.L. Stamos, H.J. Choi, W.I. Weis Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation Mol Cell 15 2004 511 521
51. J. Desbarats, M.K. Newell Fas engagement accelerates liver regeneration after partial hepatectomy Nat Med 6 2000 920 923
52. M. Grompe, S. Lindstedt, M. al-Dhalimy, N.G. Kennaway, J. Papaconstantinou, C.A. Torres-Ramos, C.N. Ou, M. Finegold Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I Nat Genet 10 1995 453 460
53. Suramin Hawking F with special reference to onchocerciasis Adv Pharmacol Chemother 15 1978 289 322
54. O. Sator, C.A. McLellan, C.E. Myers, M.M. Bonner Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines J Clin Invest 90 1992 2166 2174
55. O. Zhang, Y.F. Keng, Y. Zhao, L. Wu, Z.Y. Zhang Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases J Biol Chem 273 1998 12281 12287
56. J.C. Obenauer, L.C. Cantley, M.B. Yaffe Scansite 2.0 Proteome-wide prediction of cell signaling interactions using short sequence motifs Nucleic Acids Res 31 2003 3635 3641
57. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez A single ataxia telangiectasia gene with a product similar to PI-3 kinase Science 268 1995 1749 1753
58. R.T. Abraham Cell cycle checkpoint signaling through the ATM and ATR kinases Genes Dev 15 2001 2177 2196
59. R. Jorquera, R.M. Tanguay Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis FASEB J 13 1999 2284 2298
60. S. Kubo, M. Sun, M. Miyahara, K. Umeyama, K. Urakami, T. Yamamoto, C. Jakobs, I. Matsuda, F. Endo Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors Proc Natl Acad Sci U S A 95 1998 9552 9557
61. T. Simmen, J.E. Aslan, A.D. Blagoveshchenskaya, L. Thomas, L. Wan, Y. Xiang, S.F. Feliciangeli, C.H. Hung, C.M. Crump, G. Thomas PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis EMBO J 24 2005 717 729
62. A. Gross, X.M. Yin, K. Wang, M.C. Wei, J. Jockel, C. Milliman, H. Erdjument-Bromage, P. Tempst, S.J. Korsmeyer Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death J Biol Chem 274 1999 1156 1163
63. J. Zha, S. Weiler, K.J. Oh, M.C. Wei, S.J. Korsmeyer Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis Science 290 2000 1761 1765
64. E.K. Choi, J.S. Miller, N.F. Zaidi, E. Salih, J.D. Buxbaum, W. Wasco Phosphorylation of calsenilin at Ser63 regulates its cleavage by caspase-3 Mol Cell Neurosci 23 2003 495 506
65. Y. Takenaka, T. Fukumori, T. Yoshii, N. Oka, H. Inohara, H.R. Kim, R.S. Bresalier, A. Raz Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs Mol Cell Biol 24 2004 4395 4406
66. R. Beyaert, B. Vanhaesebroeck, W. Declercq, J. Van Lint, P. Vandenabele, P. Agostinis, J.R. Vandenheede, W. Fiers Casein kinase-1 phosphorylates the p75 tumor necrosis factor receptor and negatively regulates tumor necrosis factor signaling for apoptosis J Biol Chem 270 1995 23293 23299
67. S.S. Zinkel, C.C. Ong, D.O. Ferguson, H. Iwasaki, K. Akashi, R.T. Bronson, J.L. Kutok, F.W. Alt, S.J. Korsmeyer Proapoptotic BID is required for myeloid homeostasis and tumor suppression Genes Dev 17 2003 229 239